Apotex Inc. to Present at the 2024 Bloom Burton & Co. Annual Healthcare Investor Conference

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Apotex Inc. to Present at the 2024 Bloom Burton & Co. Annual Healthcare Investor Conference

Canada NewsWire

TORONTO, April 16, 2024 /CNW/ - Canada's largest pharmaceutical company, Apotex Inc. ("Apotex"), announced today that Allan Oberman, President & CEO, will be presenting at the 2024 Bloom Burton & Co. Annual Healthcare Investor Conference on Wednesday, April 17th, 2024 at 11:30 am EST.

About Apotex
Apotex Inc. is a Canadian-based global health company that produces high-quality, affordable and complex medicines for patients around the world, with a strategic focus on becoming a Canadian Health Champion and an Americas Partner of Choice. Apotex has an integrated portfolio of generic, biosimilar and innovative branded pharmaceutical products for global markets. Apotex employs over 7,000 people worldwide in manufacturing, R&D, and commercial operations. Apotex medicines are accessible to patients in more than 75 countries globally. Apotex is comprised of multiple divisions and affiliates, including Apotex Inc., focused on generic and specialty innovative medicines in Canada and internationally, Apotex Corp., an affiliate of Apotex Inc. which markets and sells products in the United States, and Apobiologix, a division of Apotex Inc. focused on biosimilar medicines. For more information, visit www.apotex.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/apotex-inc-to-present-at-the-2024-bloom-burton--co-annual-healthcare-investor-conference-302117355.html

SOURCE Apotex Inc.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2024/16/c0625.html

Copyright CNW Group 2024

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).